Bivalirudin Crowned as Better Anticoagulant for Primary PCI in STEMI
Gregg Stone, MD, discusses why bivalirudin could be a preferred anticoagulant for patients undergoing primary percutaneous coronary intervention (PCI).
Press Release
Inter-Atrial Shunts May Benefit Some Heart Failure Patients While Harming Others
Apr 06, 2024 View All Press ReleasesPress Release
New Treatment Approach for Advanced Coronary Artery Disease Leads to Improved Outcomes
Nov 04, 2021 View All Press Releases